In the BPH group, the phosphorylation of RB and expression of E2F1 protein was significantly increased as compared to those in the Sham group, whereas administration of Fina and COFE significantly suppressed the protein expressions (Figure 5A). The gene discussed is RB1; the disease is benign prostatic hyperplasia.